Device, patient mobility, powered
DevicePediatric mobility device
NCT Number: NCT03714256
The purpose of this study is to validate the user interface of a pediatric power mobility device by establishing that the product is safe and effective use for the intended users.
Looking for future studies?
Notify Me6 month–36 month
All sexes
Interventional
Not applicable
Cincinnati Childrens Hospital Medical Center, Cincinnati, Ohio, United States
The purpose of this study is to validate the user interface of a pediatric power mobility device by establishing that the product is safe and effective use for the intended users. The human factors validation study will be conducted in children with mobility impairments as categorised by Hays (1987) in the age range of 6 months to 36 months under realistic use conditions.The study is an open label, un-blinded, non-randomized study which consists of one visit.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Primary users:
Secondary users:
Exclusion criteria
Secondary users:
Pediatric mobility device
Time frame: One day
The tasks in this Human factors validation test, that will be performed by the users are: charge battery and disconnect it, adjust seat and table height, adjust the speed, place the child in device, adjust cushion and other support. The summary of identified errors, captured through observation and interview, will be counted and define the primary outcome
Permobil, Inc.
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05619510
Behavior, Behavioral Symptoms
Baltimore, Maryland, United States
View Trial DetailsNCT06042491
Disability Physical, Surgery-Complications
Ottawa, Ontario, Canada
View Trial DetailsNCT04927377
Diabete Type 2, Diabetes Mellitus
Birmingham, Alabama, United States
View Trial DetailsNCT05481593
Chronic Condition, Chronic Conditions, Multiple
Birmingham, Alabama, United States
View Trial Details